GE HealthCare Technologies (NASDAQ:GEHC) Trading 0.3% Higher - Should You Buy?

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) rose 0.3% on Friday . The company traded as high as $77.67 and last traded at $77.67. Approximately 1,476,253 shares traded hands during trading, a decline of 52% from the average daily volume of 3,049,545 shares. The stock had previously closed at $77.43.

Analysts Set New Price Targets

Several research firms have commented on GEHC. BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price for the company in a research report on Wednesday, September 18th. Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a report on Monday, September 30th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 price target for the company. Finally, Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average price target of $95.46.

GE HealthCare Technologies Trading Up 1.9 %

The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The firm's 50-day moving average price is $84.64 and its 200 day moving average price is $83.72. The company has a market cap of $36.05 billion, a price-to-earnings ratio of 21.68, a P/E/G ratio of 2.96 and a beta of 1.07.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion during the quarter, compared to analysts' expectations of $4.87 billion. During the same period last year, the company posted $0.99 earnings per share. The business's quarterly revenue was up .9% on a year-over-year basis. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.18%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio is 3.85%.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Mesirow Financial Investment Management Inc. grew its holdings in GE HealthCare Technologies by 39.6% during the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock worth $383,000 after buying an additional 1,159 shares in the last quarter. LMR Partners LLP purchased a new position in GE HealthCare Technologies during the 3rd quarter worth $7,387,000. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $1,396,000. Bank of Montreal Can raised its holdings in shares of GE HealthCare Technologies by 27.5% in the second quarter. Bank of Montreal Can now owns 696,446 shares of the company's stock valued at $54,964,000 after purchasing an additional 150,137 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. lifted its position in shares of GE HealthCare Technologies by 9.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company's stock valued at $13,702,000 after purchasing an additional 12,908 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.